Read the current Defeat Diabetes® E-Lerts™ Newsletter

This website is certified by Health On the Net Foundation. Click to verify.
This site complies with the HONcode standard for trustworthy health information:
verify here.

 
 
 
     
Rewarding for
you and us

Defeat Diabetes Foundation
    
      
       
Defeat Diabetes
Foundation
150 153rd Ave,
Suite 300

Madeira Beach, FL 33708
  

Insulin

Search our News Articles Archives for diabetes and health news. Search by word or phrase.  The latest article will appear first.

Search For:  

Search in all categories / subcategories
Search in current category / subcategory

New Once-daily Treatment for Type 2 Diabetes
Posted: Wednesday, July 15, 2009
A new treatment for Type 2 diabetes may soon be a reality in the U.S.. Liraglutide (Victoza), a once-daily injectable treatment for Type 2 diabetes, is pharmaceutical company Novo Nordisk's latest brain child and has been approved by the E.U.

New Link between Elevated Insulin and Breast Cancer Risk
Posted: Wednesday, July 15, 2009
Elevated insulin levels in the blood appear to raise the risk of breast cancer in postmenopausal women, according to researchers.

Lantus Insulin: Link to Cancer Shaky - Update
Posted: Wednesday, July 08, 2009
There is conflicting data over possible cancer risk from Lantus Insulin, but another alternative exists that can reduce your risk of cancer.

Lantus Insulin: A Possible Link with Cancer - Requires Further Investigation
Posted: Tuesday, June 30, 2009
Just as in the Accord study and in the Avandia debacle controversy, premature release of this kind of information before all the facts are in can be devastating for the medical community and patients. They will tell patients to consult with their physicans before making any changes to their treatment. But what can their physician tell them when they have not had any time to analyze the data and the information is not conclusive and more studies are needed?

This premature release states that Sanofi-Aventis's diabetes drug Lantus may increase the risk of cancer, according to European studies involving some 300,000 insulin-treated patients, prompting a call from experts for more research.

Depression Linked to Low Insulin Sensitivity in Type 2 Diabetes
Posted: Tuesday, June 30, 2009
Researchers at the University of Connecticut in Farmington report that depression is associated with low insulin sensitivity and that treatment of depression decreases insulin resistance. "Depressed subjects have a 37% increased risk of developing diabetes."

Body Chemistry Identifies Type 2 Risk
Posted: Tuesday, June 30, 2009
Researchers studying 6,538 people in the UK over almost 10 years found specific changes in blood glucose levels and sensitivity to the hormone insulin.

Gene Inhibition Helps to Normalize Type 2 Diabetes
Posted: Tuesday, June 30, 2009
In research that could lead to new approaches for the treatment of Type 2 diabetes, a research team has found that suppressing a liver enzyme that induces glucose production helped diminish the symptoms of the disease — reducing blood glucose concentrations, decreasing rates of glucose production in the liver, and improving insulin sensitivity.

New Possible Bone Marrow Stem Cell Therapy for Diabetes
Posted: Wednesday, June 24, 2009
Dr. Aaron Vinik, principle investigator for the study at Eastern Virginia Medical School in Norfolk, is testing a new diabetes drug, Prochymal. It’s part of a first-of-its-kind study for finding a possible cure.

Using Vitamin C Plus Insulin to Stop Diabetes Damage
Posted: Wednesday, June 24, 2009
Researchers have found a way to stop the damage caused by Type 1 diabetes with the combination of insulin and a common vitamin found in most medicine cabinets. This simply means that getting your glucose under control is not enough.

Inhaled Insulin AFRESA(R) Controls Post-Meal Sugar Levels with Less Weight Gain and Hypoglycemia
Posted: Wednesday, June 17, 2009
The findings of two 52-week studies show that the investigational ultra rapid acting insulin AFRESA® (insulin human [rDNA origin]) Inhalation Powder combined with basal insulin is comparable to standard of care therapies in controlling post-meal blood sugar levels, and also results in significantly less weight gain and risk of hypoglycemia for adult patients with diabetes.

Page 12 of 32
 |<   <<   <  7  |  8  |  9  |  10  |  11  |  12  |  13  |  14  |  15  |  16  |  17  >   >>   >| 

 
 
 
 
 
Join us on Facebook
 
 
 
 Costa Rica Travel Corp. will donate a portion of the proceeds to and is a sponsor of Defeat Diabetes Foundation.  
 
 

Send your unopened, unexpired test strips to:


Defeat Diabetes Foundation
150 153rd Ave, Suite 300
Madeira Beach, FL 33708

 

DDF advertisement
 

 Friendly Banner
 


Friendly Banner
 
 
 
Analyze nutrition content by portion
DDF advertisement